Study: Diabetes tied to mortality, hospitalization in heart failure patients | Analysis: AFib risk higher with sleep disorders | Study looks at peripartum cardiomyopathy risk among black women
October 18, 2017
Cardiometabolic Health SmartBrief
SIGN UP ⋅   FORWARD
Top Story
Study: Diabetes tied to mortality, hospitalization in heart failure patients
A study in JACC: Heart Failure showed that heart failure patients with type 2 diabetes had an increased risk of first hospitalization and mortality, compared with those without diabetes. UK researchers also found that type 2 diabetes stratified by glycemic control and drug treatments had differential risk associations with hospitalization and mortality.
Physician's Briefing/HealthDay News (10/12) 
LinkedIn Twitter Facebook Google+ Email
Learn In Demand Skills in Health Care
GW's clinical research, health care quality and regulatory affairs programs prepare you to become a leader, able to meet the evolving nature of health care.
Learn More
ADVERTISEMENT
Science & Research
Analysis: AFib risk higher with sleep disorders
A study presented at the Cardiometabolic Health Conference found that patients with obstructive sleep apnea or sleep-disordered breathing were at greater risk for atrial fibrillation, a factor in increased cardiovascular morbidity and mortality.
Healio (free registration)/Cardiology Today (10/16) 
LinkedIn Twitter Facebook Google+ Email
Study looks at peripartum cardiomyopathy risk among black women
A single-center study in JAMA Cardiology found black women were at a greater risk of having peripartum cardiomyopathy, compared with other women. Among the 220 women in the study, black patients took more than twice the time to recover.
Cardiovascular Business online (10/12) 
LinkedIn Twitter Facebook Google+ Email
Study: Antihypertensive drugs don't fully reverse all vessel damage
A UK study in Frontiers in Physiology found that despite the efficacy of antihypertensive treatments in lowering blood pressure and restoring normal function in arterioles and larger vessels, these drugs failed to restore normal vascular rhythms in smaller vessels. The findings were based on a cohort of patients in their 20s and two cohorts of patients older than 70 years.
Cardiovascular Business online (10/16) 
LinkedIn Twitter Facebook Google+ Email
Researchers call for earlier CVD tests for women with PCOS
Women who have polycystic ovary syndrome have a higher risk of cardiovascular disease and should get CVD screening at a younger age than healthy women, researchers told the North American Menopause Society's annual meeting. Researchers suggested fasting lipid profiles be done every two years and that screenings for obesity and hypertension be performed at each visit.
Healio (free registration)/Endocrine Today (10/14) 
LinkedIn Twitter Facebook Google+ Email
Lifestyle & Wellness
Study shows benefits of maintaining healthy weight to BP control
Researchers analyzed data on 4,630 participants, ages 18 to 30, and found that those who maintained optimal body weight had a 41% reduced risk of having an increase in blood pressure levels as they aged, compared with those who did not maintain a healthy weight. The findings, presented at the 2017 American Heart Association Council on Hypertension, AHA Council on Kidney in Cardiovascular Disease, American Society of Hypertension Joint Scientific Sessions, also revealed that maintaining at least four healthy behaviors was tied to 27% higher odds of having normal BP, rather than increasing BP, from early adulthood to middle age.
Medscape (free registration) (10/12) 
LinkedIn Twitter Facebook Google+ Email
RD: More research needed on optimal ratio for fatty acids
Nutrition experts agree omega-3 fatty acids reduce inflammation and have health benefits, but questions remain about how much dietary omega-6 fatty acids are needed and the best ratio of omega-6s to omega-3s, said registered dietitian Densie Webb. The American Heart Association recommends that omega-6 fatty acids make up at least 5% to 10% of calories, but research on the ratio of omega-3s to omega-6s is inconsistent.
Today's Dietitian (10/2017) 
LinkedIn Twitter Facebook Google+ Email
Patients who refuse cardiac rehab may benefit from tai chi
Coronary artery disease patients who will not participate in cardiac rehabilitation programs may benefit from regular tai chi sessions, according to a study in the Journal of the American Heart Association. Patients who did tai chi three times per week reported higher levels of physical activity, quality of life and weight loss compared with those who attended twice per week.
Healio (free registration)/Cardiology Today (10/11) 
LinkedIn Twitter Facebook Google+ Email
Practice Trends & Technology
Pfizer's neuropathic pain drug approved by FDA
The FDA has approved Pfizer's Lyrica CR, or pregabalin, extended-release tablets CV as a once-a-day treatment for patients with neuropathic pain related to diabetic peripheral neuropathy and postherpetic neuralgia. A clinical trial demonstrated at least 50% improvement in pain intensity in 73.6% of patients who used Lyrica CR compared with 54.6% who received placebo.
Seeking Alpha (free registration) (10/12) 
LinkedIn Twitter Facebook Google+ Email
Review by FDA finds semaglutide effective as a diabetes treatment
A preliminary review by the FDA found that Novo Nordisk's semaglutide, a once-weekly injection, is an effective treatment for diabetes, carries only a limited risk of diabetic retinopathy and did not cause heart risk. The findings, based on an analysis of clinical trial data, revealed that semaglutide reduced blood glucose levels and resulted in greater weight loss compared with other GLP-1 receptor agonists.
Reuters (10/16) 
LinkedIn Twitter Facebook Google+ Email
Cardiometabolic Health Congress News
CMHC West 2018
CMHC West 2018
Register for CMHC West today!
Back by popular demand, CMHC brings you the 2018 CMHC West: Advancing Cardiometabolic Health from East to West in Las Vegas, Nev., May 4-5, 2018. CMHC West will capture the integrity and high-quality education of the annual Cardiometabolic Health Congress as the nation's top experts in cardiometabolic health will highlight the latest updates in hypertension, heart failure, diabetes, lifestyle management and cardiovascular health.
Earn up to 10 CME/CE Credits!
LinkedIn Twitter Facebook Google+ Email
 
Virtual Patient Case: Navigating the Diagnosis and Management of Statin Intolerance in the Cardiometabolic Patient
1.0 Credit Hour
The interactive virtual patient case activity will incorporate a multiple-choice format that offers a "test-and-teach" approach for clinicians. In each case, learners will be presented with history, symptoms, labs, and tests as appropriate in order to enable learners to make a choice regarding assessment and management. They will then be presented with possible treatment modalities, effective communication tools, and other data, enabling the assessment of the risks/benefits of each choice. Learners then review an overview of the patient's situation before reviewing the patient's chart, a patient interview, physical examination, laboratory tests (if appropriate), diagnosis, treatment, and follow-up. Data are collected throughout the activity as learners answer questions and demonstrate how they would proceed with this particular patient.
Learn more about CMHC:
Home page | Online Education program menu home page | CMHC Boston 2017
CMHC 2017 Regional Conference Series | About CMHC page
  
  
Failure is an event -- it is not a person.
Zig Ziglar,
writer and motivational speaker
LinkedIn Twitter Facebook Google+ Email
  
  
Sign Up
SmartBrief offers 200+ newsletters
Advertise
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Lauren Barr
Editor  -  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information